Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Debt Ratio & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Debt Ratio

LCTX Debt Ratio

Current (TTM)2.16%retrievedOct 20, 2026

LCTX Debt Ratio (0.00% → 2.16%)

Latest values, visible window

High-resolution chart · PNG

LCTX debt ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Debt Ratio — Annual fiscal periods
Period ending	Debt Ratio
Dec 31, 2025	2.1486%
Dec 31, 2024	2.2205%
Dec 31, 2023	2.9222%
Dec 31, 2022	3.1505%
Dec 31, 2021	1.6053%
Dec 31, 2020	3.5433%
Dec 31, 2019	4.1187%
Dec 31, 2018	2.228%
Dec 31, 2017	0.8849%
Dec 31, 2016	2.793%
Dec 31, 2015	5.3909%
Dec 31, 2014	0.7036%
Dec 31, 2013	0%
Dec 31, 2012	0%
Dec 31, 2011	0%
Dec 31, 2010	0%
Dec 31, 2009	0%
Dec 31, 2008	182.1127%
Dec 31, 2007	409.2112%
Dec 31, 2006	0%
Dec 31, 2005	0%
Dec 31, 2004	0%
Dec 31, 2003	250.6094%
Dec 31, 2002	144.9657%
Dec 31, 2001	89.1699%
Dec 31, 2000	0%
Dec 31, 1999	0%
Dec 31, 1998	0%
Jun 30, 1998	0%
Jun 30, 1996	0%
Jun 30, 1995	0%
Jun 30, 1994	0%
Jun 30, 1993	0%
Jun 30, 1992	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.